This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Perseus Proteomics Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovations of Shin Ohnishi
Introduction
Shin Ohnishi is a notable inventor based in Bunkyo, Japan. He has made significant contributions to the field of medical technology, particularly in cancer prognosis. His work focuses on improving the methods used to predict the recurrence of liver cancer after treatment.
Latest Patents
Ohnishi holds a patent for a method titled "Method for predicting and judging the recurrence of liver cancer after treating liver cancer." This innovative approach is characterized by measuring GPC3 contained in a test sample using an anti-GPC3 antibody. This method aims to enhance the accuracy of prognosing possible recurrence after treatment of liver cancer.
Career Highlights
Shin Ohnishi is associated with Perseus Proteomics Inc., where he applies his expertise in proteomics to develop advanced diagnostic tools. His work has the potential to significantly impact patient outcomes in liver cancer treatment.
Collaborations
Ohnishi has collaborated with notable colleagues, including Hiroko Iwanari and Hiroyuki Aburatani. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Shin Ohnishi's contributions to cancer prognosis through his innovative patent demonstrate his commitment to improving medical technology. His work continues to pave the way for advancements in the treatment and management of liver cancer.